These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9081826)

  • 1. [Hypersensitization to protamine-containing insulin].
    Räsänen L; Tuomi ML; Lahtela J; Knip M
    Duodecim; 1995; 111(10):914-8. PubMed ID: 9081826
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immediate protamine sulphate allergy in an insulin-treated diabetic patient].
    Petäys T; Kiistala R; Mäkinen-Kiljunen S
    Duodecim; 1999; 115(5):517-20. PubMed ID: 11830901
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment possibilities of insulin resistance].
    Bornemisza P
    Z Gesamte Inn Med; 1969 Apr; 24(8):234-7. PubMed ID: 4308358
    [No Abstract]   [Full Text] [Related]  

  • 5. Case of generalized allergy due to zinc and protamine in insulin preparation.
    Bruni S; Barolo P; Gamba S; Grassi G; Blatto A
    Diabetes Care; 1986; 9(5):552. PubMed ID: 3769725
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin.
    Adachi A; Fukunaga A; Horikawa T
    Int J Dermatol; 2004 Aug; 43(8):597-9. PubMed ID: 15304187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
    Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
    Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of long-acting insulin analogs].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Apr; 126(8):1067-8. PubMed ID: 16619068
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin allergy: background, diagnosis and treatment].
    Wonders J; Eekhoff EM; Heine R; Bruynzeel DP; Rustemeyer T
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2783-8. PubMed ID: 16385830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allergy to biogenetic human protamine insulin with a marked increase in anti-insulin antibody levels and blood eosinophils].
    Chenon D; Fabro M; Richard JL; Rimbaud Y; Mirouze J; Blayac JP
    Presse Med; 1989 Jul; 18(26):1297-8. PubMed ID: 2528136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anaphylactic shock due to highly purified porcine insulin].
    Menoscal A; Lavarello A; García de los Ríos M
    Rev Med Chil; 1986 Oct; 114(10):969-72. PubMed ID: 3107101
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of A-C bypass with protamine hypersensitivity].
    Tsuji Y; Goto T; Matsumoto Y; Shio K
    Kyobu Geka; 1986 Dec; 39(12):973-6. PubMed ID: 3493380
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reaction to a biosimilar insulin glargine.
    García-Nares H; Leyva-Carmona MI; Pérez-Xochipa N; Chiquete E
    J Diabetes; 2015 Mar; 7(2):155-7. PubMed ID: 25350350
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin glargine use and short-term incidence of breast cancer - a four-year population-based observation.
    Ljung R; Talbäck M; Haglund B; Jonasson JM; Gudbjörnsdòttir S; Steineck G
    Acta Oncol; 2012 Mar; 51(3):400-2. PubMed ID: 22497435
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systemic and local allergy to human insulin].
    Wittrup M; Pildal J; Rasmussen AK; Skov BG; Petersen J; Mandrup-Poulsen TR
    Ugeskr Laeger; 2003 May; 165(21):2207-8. PubMed ID: 12820512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-induced drug eruptions and reliability of skin tests.
    Lee AY; Chey WY; Choi J; Jeon JS
    Acta Derm Venereol; 2002; 82(2):114-7. PubMed ID: 12125938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine sulphate hypersensitivity.
    Doolan L; McKenzie I; Krafchek J; Parsons B; Buxton B
    Anaesth Intensive Care; 1981 May; 9(2):147-9. PubMed ID: 7258612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA raises concerns about ultra-long acting insulins given green light in Europe and Japan.
    Torjesen I
    BMJ; 2012 Oct; 345():e7323. PubMed ID: 23112064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.